PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Bruker Corporation

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Bruker Announces MALDI PharmaPulse™ - A Breakthrough High-Throughput Screening (HTS) Solution for Drug Discovery - Label-free, MALDI-based HTS ‘in a heartbeat’ at 1 second assay time (~50,000 assays per day) with 100x less solvent cost, and faster assay development, represents a paradigm change in mass spectrometry-based HTS - Bruker.com
Bruker Announces MALDI PharmaPulse™ - A Breakthrough High-Throughput Screening (HTS) Solution for Drug Discovery

 

NewswireToday - /newswire/ - St. Louis, MI, United States, 2015/06/08 - Label-free, MALDI-based HTS ‘in a heartbeat’ at 1 second assay time (~50,000 assays per day) with 100x less solvent cost, and faster assay development, represents a paradigm change in mass spectrometry-based HTS - Bruker.com. NASDAQ: BRKR

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Electronics/Instrumentation/RFID Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

At the 63rd ASMS Conference on Mass Spectrometry and Allied Topics, Bruker today announced a new high-throughput screening (HTS) solution designed to help pharmaceutical companies achieve high throughput, lower cost and higher specificity in drug discovery. The new MALDI PharmaPulse™ solution combines the speed, sensitivity and ease-of-use of Bruker's robust MALDI-TOF systems with industry-leading HTS robotics and automation software from HighRes Biosolutions, Inc. of Woburn, MA.

The new MALDI PharmaPulse solution is the latest addition to Bruker's portfolio of innovative products designed to assist pharmaceutical, biotech and CRO customers accelerate drug discovery and development. Based on the autoflex™ speed MALDI TOF system, and incorporating an integrated automation solution from HighRes Biosolutions, this new HTS solution offers the fastest commercially available mass spectrometry-based screening solution with significantly lower cost per sample. In addition, its label-free detection of substrates accelerates assay development, reduces complexity of screening, and potentially minimizes artifacts from interferences with the labels used in traditional HTS technologies.

The unique capabilities of the novel MALDI PharmaPulse solution for driving higher throughput at dramatically lower costs for screening in drug discovery, include:

• Less than 1 second per sample analysis time, comparable to the pulse of the human heart, and fast enough for true high throughput screening (HTS);
• autoflex speed MALDI TOF equipped with proprietary 2 kHz smartbeam™-II laser;
• Integrated automation solution from HighRes Biosolutions seamlessly prepares and feeds MALDI plates from 96, 384 or 1536 assay plates;
• MALDI-detection removes need for SPE cartridges or LC columns, uses 100x less solvent per sample than conventional LC-MS methods;
• Does not require derivatization in comparison to fluorescence workflows;
• Development times for new assays and complexity is dramatically reduced without the need for chromatographic method development, SPE or MRM setup, or derivatization protocols;
• The extremely low sample volumes required for detection (typically ~1 mL) enables "Single Well Kinetic Readout" by sampling multiple time points per assay;
• The full automation, coupled with speed of MALDI TOF, enables the screening of over 50.000 compounds per day.

Due to this unique feature set, the MALDI PharmaPulse enables pharmaceutical customers to accelerate their drug discovery efforts with higher throughput assays, delivering higher quality results while lowering costs.

Dr. Paul Speir, Senior Vice President for the Americas of the Bruker Daltonics division, stated: "The unique MALDI PharmaPulse solution was developed in close collaboration with leading HTS scientists in the pharmaceutical industry. These types of collaborative projects enable Bruker to deliver integrated solutions that truly meet the emerging needs of pharma customers looking for breakthroughs."

About Bruker Corporation
For more than 50 years, Bruker has enabled scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific research instruments and high-value analytical solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels.

In close cooperation with our customers, Bruker is enabling innovation, productivity and customer success in life science molecular research, in applied and pharma applications, and in microscopy, nano-analysis and industrial applications, as well as in cell biology, preclinical imaging, clinical research, microbiology and molecular diagnostics.

Investor Contact: Joshua Young - Vice President of Investor Relations, Bruker Corporation
T: +1 978-663-3660 x1479 - E: joshua.young[.]bruker.com.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Electronics/Instrumentation/RFID Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Bruker Corporation

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Electronics/Instrumentation/RFID articles,
CATCH Visitors via Your Competitors Announcements!


Bruker Announces MALDI PharmaPulse™ - A Breakthrough High-Throughput Screening (HTS) Solution for Drug Discovery

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Bruker Corporation | MALDI PharmaPulse™
Publisher Contact: Tony Lewtas - Bruker Daltonics 
978 663 3660 x1212 tony.lewtas[.]bruker.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Bruker Corporation securities in any jurisdiction including any other companies listed or named in this release.

Electronics/Instrumentation/RFID via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Bruker Corporation / Company Profile


Read Electronics/Instrumentation/RFID Most Recent Related Newswires:

GE Ventures, Microsemi and Corning Partner to Launch Menlo Micro and Next Generation of Electronic Switching
Frost & Sullivan Commends LeEco for Driving Innovation in the North American Smart Technologies Market
Malvern Instruments and PANalytical to Merge
Bruker Announces Corporate Partnership with International Phenome Centre Network (IPCN) for NMR Technologies and SOPs
Predictive and Control Capabilities through IoT Rapidly Expand Global Growth Opportunities for Sensors Finds Frost & Sullivan
IDEX Showcased the World’s First Flexible Touch Fingerprint Sensor for SmartCards and Receives Massive Industry Interest
Endress+Hauser Consult AG Introduces Proline 300/500 - Flow Measuring Technology for the Future
Lipigas Delivers Enhanced Interactive and Visual Mobile Self-Service Portal Using Joint Visual IVR Solution from Dialogic and Telectronic
Customized Electronic Ticket Solutions Simplify Daily Commute in Russian Cities
Bruker AXS Introduces A New Member to The D8 ADVANCE Family - The D8 ADVANCE Plus™
Spellman to Exhibit at the 2016 Radiological Society of North America Meeting in Chicago
Infineon Teams Up with Chinese Appliance Manufacturers for Solutions
Infineon Raises its Through-cycle Target for The Segment Result Margin to 17 Percent
Smartphones and Wearables Market Poised for Growth with Next-Generation Sensors Key Enabler of Innovation
Infineon Complements IMOTION™ Modular Application Design Kit with Two Power Boards

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Triggr & Bloom

Visit  BizJobs.com





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)